{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:47:59Z","timestamp":1772815679732,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf02246108","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T10:33:53Z","timestamp":1132050833000},"page":"333-339","source":"Crossref","is-referenced-by-count":12,"title":["Comparative anterograde amnestic and anticonvulsant effects of two types of NMDA receptor antagonists: MK-801 and HA-966"],"prefix":"10.1007","volume":"117","author":[{"given":"X.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02246108_CR1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.146.3646.952","volume":"146","author":"BW Agranoff","year":"1964","unstructured":"Agranoff BW, Klinger PD (1964) Puromycin effect on memory fixation in the goldfish. Science 146:952\u2013953","journal-title":"Science"},{"key":"BF02246108_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0091-3057(88)90445-5","volume":"30","author":"MJ Benvenga","year":"1988","unstructured":"Benvenga MJ, Spaulding TC (1988) Amnestic effect of the novel anticonvulsant MK-801. Pharmacol Biochem Behav 30:205\u2013207","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246108_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0166-2236(87)90170-6","volume":"10","author":"CW Cotman","year":"1987","unstructured":"Cotman CW, Iversen LL (1987) Excitatory amino acids in the brainfocus on NMDA receptors. Trends Neurosci 10:263\u2013265","journal-title":"Trends Neurosci"},{"key":"BF02246108_CR4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0028-3908(88)90189-X","volume":"27","author":"W Danysz","year":"1988","unstructured":"Danysz W, Wroblewski JT, Costa Z (1988) Learning impairment in rats byN-methyl-d-aspartate receptor antagonists. Neuropharmacology 27:653\u2013656","journal-title":"Neuropharmacology"},{"key":"BF02246108_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/newbio238061a0","volume":"238","author":"J Davies","year":"1972","unstructured":"Davies J, Watkins JC (1972) Is 1-hydroxy-3-amino-pyrrolidone-2 a selective excitatory amino acid antagonist? Nature New Biol 238:61\u201363","journal-title":"Nature New Biol"},{"key":"BF02246108_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0006-8993(78)90744-8","volume":"148","author":"RJ Evans","year":"1978","unstructured":"Evans RJ, Francis AA, Watkins JC (1978) Mg2+-like selective antagonism of excitatory amino acid-induced responses by alpha, epsilo-diaminopimelic acid,d-alpha-aminoadipate and HA-966 in isolated spinal cord of frog and immature rat. Brain Res 148:526\u2013542","journal-title":"Brain Res"},{"key":"BF02246108_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(88)90711-X","volume":"151","author":"EJ Fletcher","year":"1988","unstructured":"Fletcher EJ, Lodge D (1988) Glycine reverse antagonism ofN-methyl-d-aspartate (NMDA) by 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) but not byd-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices. Eur J Pharmacol 151:161\u2013162","journal-title":"Eur J Pharmacol"},{"key":"BF02246108_CR8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1523\/JNEUROSCI.09-06-02191.1989","volume":"9","author":"AC Foster","year":"1989","unstructured":"Foster AC, Kemp JA (1989) HA-966 antagonizesN-methyl-d-aspartate receptors through a selective interaction with the glycine modulatory site. J Neurosci 9:2191\u20132196","journal-title":"J Neurosci"},{"key":"BF02246108_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(90)90140-D","volume":"36","author":"N Heale","year":"1990","unstructured":"Heale N, Harley C (1990) MK-801 and AP5 impair acquisition, but not retention, of the Morris Milk Maze. Pharmacol Biochem Behav 36:145\u2013149","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246108_CR10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1037\/0735-7044.105.1.126","volume":"105","author":"JJ Kim","year":"1991","unstructured":"Kim JJ, DeCola JP, Landeira-Fernandez J, Fanselow MS (1991)N-Methyl-d-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav Neurosci 105:126\u2013133","journal-title":"Behav Neurosci"},{"key":"BF02246108_CR11","first-page":"349","volume":"252","author":"W Koek","year":"1990","unstructured":"Koek W, Colpaert FC (1990) Selective blockade of NMDA-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effect. J Pharmacol Exp Ther 252:349\u2013357","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246108_CR12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/345716a0","volume":"345","author":"MJP Miserendino","year":"1990","unstructured":"Miserendino MJP, Sananes CB, Melia KR, Davis M (1990) Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345:716\u2013718","journal-title":"Nature"},{"key":"BF02246108_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pa.29.040189.002053","volume":"29","author":"DT Monaghan","year":"1989","unstructured":"Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365\u2013402","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF02246108_CR14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/319774a0","volume":"319","author":"RGM Morris","year":"1986","unstructured":"Morris RGM, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by anN-methyl-d-aspartate receptor antagonist, AP5. Nature 319:774\u2013776","journal-title":"Nature"},{"key":"BF02246108_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1098\/rstb.1990.0164","volume":"329","author":"RGM Morris","year":"1990","unstructured":"Morris RGM, Davis S, Butcher SP (1990) Hippocampal synaptic plasticity and NMDA receptors: a role information storage? Philos Transa R Soc Lond B 329:187\u2013204","journal-title":"Philos Transa R Soc Lond B"},{"issue":"12","key":"BF02246108_CR16","first-page":"111","volume":"29","author":"J Parada-Turska","year":"1990","unstructured":"Parada-Turska J, Turski WA (1990) Excitatory amino acid antagonists and memory effects of drugs acting atN-methyl-d-aspartate receptors in learning and memory tasks. Neuropharmacology 29[12]:111\u2013116","journal-title":"Neuropharmacology"},{"key":"BF02246108_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02244550","volume":"104","author":"DJ Sanger","year":"1991","unstructured":"Sanger DJ, Joly D (1991) Effects of NMDA receptor antagonists andsigma ligands on the acquisition of conditioned fear in mice. Psychopharmacology 104:27\u201334","journal-title":"Psychopharmacology"},{"key":"BF02246108_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0166-4328(85)90027-0","volume":"18","author":"BE Schlumpf","year":"1985","unstructured":"Schlumpf BE, Davis RE (1985) Vision in goldfish following bilateral tectal ablation. Behav Brain Res 18:193\u2013199","journal-title":"Behav Brain Res"},{"key":"BF02246108_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3758\/BF03327232","volume":"18","author":"M Shapiro","year":"1990","unstructured":"Shapiro M, Caramanos Z (1990) NMDA antagonist MK-801 impairs acquisition but not performance of spatial working and reference memory. Psychobiology 18:231\u2013243","journal-title":"Psychobiology"},{"key":"BF02246108_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1073\/pnas.87.1.347","volume":"87","author":"L Singh","year":"1990","unstructured":"Singh L, Donald AE, Foster AC, Huston PH, Iversen LL, Iversen SD, Kemp JA, Leeson PD, Marshall GR, Vass GA, Williams BJ (1990) Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)HA-966 is a selective glycine\/N-methyl-d-aspartate receptor antagonist, but (\u2212)HA-966 is a potent \u03b3-butyrolactone-like sedative. Proc Natl Acad Sci USA 87:347\u2013351","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"BF02246108_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/0735-7044.103.1.54","volume":"103","author":"U Staubli","year":"1989","unstructured":"Staubli U, Thibault O, DiLorenzo M, Lynch G (1989) Antagonism of NMDA receptors impairs acquisition but not retention of olfactory memory. Behavioral Neuroscience 103[1]:54\u201360","journal-title":"Behavioral Neuroscience"},{"key":"BF02246108_CR22","volume-title":"Manual of pharmacologic calculations with computer programs","author":"RJ Tallarida","year":"1987","unstructured":"Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs, 2nd edn. Springer, New York","edition":"2nd edn."},{"key":"BF02246108_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(85)90429-9","volume":"336","author":"L Turski","year":"1985","unstructured":"Turski L, Meldrum BS, Collins JF (1985) Anticonvulsant action of beta-kainic acid in mice: is beta-kainic acid anN-methyl-d-aspartate antagonist? Brain Res 336:162\u2013166","journal-title":"Brain Res"},{"key":"BF02246108_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0091-3057(90)90359-P","volume":"35","author":"L Ward","year":"1990","unstructured":"Ward L, Masom SE, Abraham WC (1990) Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol Biochem Behav 35:785\u2013790","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246108_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF00441949","volume":"98","author":"IQ Whishaw","year":"1989","unstructured":"Whishaw IQ, Auer RN (1989) Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology 98:500\u2013507","journal-title":"Psychopharmacology"},{"key":"BF02246108_CR26","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","volume":"83","author":"EHF Wong","year":"1986","unstructured":"Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potentN-methyl-d-aspartate antagonist. Proc Natl Acad Sci USA 83:7104\u20137108","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02246108_CR27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1471-4159.1988.tb13260.x","volume":"50","author":"EHF Wong","year":"1988","unstructured":"Wong EHF, Knight AR, Woodruff GN (1988) [3H]MK-801 labels a site on theN-methyl-d-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274","journal-title":"J Neurochem"},{"issue":"2","key":"BF02246108_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1037\/0735-7044.106.2.307","volume":"106","author":"X Xu","year":"1992","unstructured":"Xu X, Davis RE (1992)N-Methyl-d-aspartate receptor antagonist MK-801 impairs learning but not memory fixation or expression of classical fear conditioning in goldfish (Carassius auratus) Behav Neurosci 106[2]:307\u2013314","journal-title":"Behav Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246108\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T12:17:43Z","timestamp":1683289063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF02246108"],"URL":"https:\/\/doi.org\/10.1007\/bf02246108","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}